Anúncio
Anúncio

BCAB

BCAB logo

BioAtla, Inc. Common Stock

0.36
USD
Patrocinado
-0.04
-10.13%
09 de jan., 15:55 UTC -5
Encerrado
exchange

Pós-Mercado

0.37

+0.01
+3.61%

Relatórios de Lucros BCAB

Rácio de surpresa positiva

BCAB separação 14 de 20 últimas estimativas.

70%

Próximo Relatório

Data do Próximo Relatório
25 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.24
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
-11.11%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
-20.00%

BioAtla, Inc. Common Stock earnings per share and revenue

On 13 de nov. de 2025, BCAB reported earnings of -0.27 USD per share (EPS) for Q3 25, beating the estimate of -0.30 USD, resulting in a 10.77% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +19.75% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.24 USD, with revenue projected to reach -- USD, implying an diminuir of -11.11% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, BioAtla, Inc. Common Stock reported EPS of -$0.27, beating estimates by 10.77%, and revenue of $0.00, 0% as expectations.
The stock price moved up 19.75%, changed from $0.66 before the earnings release to $0.79 the day after.
The next earning report is scheduled for 25 de mar. de 2026.
Based on 3 analistas, BioAtla, Inc. Common Stock is expected to report EPS of -$0.24 and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio